A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Jackson CG, Moore KN, Cantrell L, Erickson BK, et al. Gynecol Oncol 2022 Apr 28. pii: S0090-8258(22)00257.

Read + Share

Amedeo Smart

Independent Medical Education

Jackson CG, Moore KN, Cantrell L, Erickson BK, et al. A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol 2022 Apr 28. pii: S0090-8258(22)00257.
PMID: 35491267